Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07453732 · ClinicalTrials.gov registry record · NA
Banana Leaves as a Wound Dressing for Partial Thickness Second Degree Burns in Adult Patients.
A NA study, sponsored by University of Colorado, Denver.
- Not yet
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT07453732: Clinical Trial NA study, sponsored by University of Colorado, Denver.
NCT07453732 is a NA study that has not yet begun recruiting, run by University of Colorado, Denver. The registered enrollment target is 30 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07453732, a NA study, has not yet begun recruiting, sponsored by University of Colorado, Denver.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
This study plans to look at the benefits of banana leaves as a primary burn wound dressing. Study patients will be compared to historical patients
Primary Outcome
The Numeric Pain Rating Scale is a unidimensional subjective measure of pain intensity in adults, consisting of a scale from 0 to 10, where 0 represents "no pain" and 10 represents "worst pain imaginable" (or "worst possible pain").
Interventions
- DEVICE Banana leaf dressing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2026-04-01 |
| Est. Completion | 2027-04-30 |
| Phase | NA |
What is known before NCT07453732 opens enrollment
NCT07453732 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 1 intervention - of which Banana leaf dressing is the first listed.
NCT07453732 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07453732 about?
NCT07453732 is a clinical study titled "Banana Leaves as a Wound Dressing for Partial Thickness Second Degree Burns in Adult Patients.". This study plans to look at the benefits of banana leaves as a primary burn wound dressing. Study patients will be compared to historical patients
What is the current status of trial NCT07453732?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2026-04-01. Estimated completion is 2027-04-30.
What interventions are being tested in trial NCT07453732?
The interventions under investigation include: Banana leaf dressing (DEVICE).
Who is sponsoring clinical trial NCT07453732?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07453732's enrollment target sits among peer trials
30 1593rd of 2000 higher than 299 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI